S-23

S23 suppresses harder than anything else in the category

S-23 is a non-steroidal SARM with unusually high binding affinity and full agonist activity at the androgen receptor. This section holds 5 lines from £84 to £108, averaging near £93.

Among the compounds in the SARMs range it is consistently the most suppressive, and that is not incidental to what it is.

The contraceptive research

Like trestolone, S-23 was investigated as a male contraceptive. In animal studies it produced reversible infertility through complete suppression of spermatogenesis, with fertility returning after discontinuation.

A compound selected for its ability to shut down the reproductive axis will shut down the reproductive axis. Anyone choosing SARMs specifically to avoid the suppression associated with steroids has picked the worst possible option in the category.

Why people use it anyway

The same properties that make it suppressive make it effective. Full agonist activity and high binding affinity mean stronger effects than the partial agonists like ostarine, and users report results closer to a steroid than to the milder SARMs.

That is a coherent reason to choose it. What is not coherent is choosing it while expecting SARM-level mildness.

What it requires

A serious post cycle therapy plan, decided before starting. Suppression of this degree does not resolve on its own quickly, and recovery is the part people underestimate.

It is also strongly implicated in raised blood pressure and adverse lipid changes, both common across the more potent SARMs and both invisible without measurement.

Status

S-23 is not a licensed medicine anywhere and is sold for research purposes. It is prohibited in sport at all times. Human data is essentially absent — the evidence base is animal work at contraceptive endpoints. Verification is covered in how to check a brand is genuine.

Where the confusion comes from

SARMs acquired a reputation as a milder alternative to steroids, and that framing gets applied to the whole category regardless of the individual compound. S-23 is the clearest counter-example: a full agonist selected for total axis suppression, sitting on the same shelf as compounds chosen for the opposite property.

Category-level reasoning fails badly here. The compounds in this range differ from each other more than the label suggests.

Frequently asked questions

Is S-23 the strongest SARM?
Among those stocked it has the highest binding affinity and full agonist activity, and the strongest effects.

How suppressive is it?
The most suppressive in the category. It was studied as a contraceptive for exactly that reason.

Does it need PCT?
Yes, and a serious one planned in advance rather than assembled afterwards.

Is there human data?
Essentially none. The evidence base is animal contraceptive research.

Is it a good first SARM?
No. It is the least mild option in a category people choose for mildness.